SG Americas Securities, LLC - ARENA PHARMACEUTICALS INC ownership

ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 120 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of ARENA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$316,000
-63.6%
3,403
-76.6%
0.00%
-50.0%
Q3 2021$868,000
+21.9%
14,569
+39.5%
0.00%
+33.3%
Q2 2021$712,000
+73.7%
10,446
+76.9%
0.00%
+50.0%
Q1 2021$410,000
+210.6%
5,904
+244.7%
0.00%
+100.0%
Q4 2020$132,000
-90.7%
1,713
-91.0%
0.00%
-88.9%
Q3 2020$1,424,000
-57.7%
19,035
-64.4%
0.01%
-67.9%
Q2 2020$3,365,000
+41.2%
53,457
-5.8%
0.03%
+27.3%
Q1 2020$2,383,000
+127.0%
56,749
+145.4%
0.02%
+120.0%
Q4 2019$1,050,000
-40.0%
23,121
-39.6%
0.01%
-28.6%
Q3 2019$1,751,000
+1083.1%
38,266
+1417.3%
0.01%
+1300.0%
Q2 2019$148,000
-86.3%
2,522
-89.5%
0.00%
-90.0%
Q1 2019$1,080,000
+150.6%
24,097
+118.0%
0.01%
+150.0%
Q4 2018$431,000
+68.4%
11,055
+88.3%
0.00%
+100.0%
Q2 2018$256,000
-16.6%
5,872
-24.5%
0.00%0.0%
Q1 2018$307,000
+147.6%
7,776
+5.8%
0.00%
+100.0%
Q2 2017$124,0007,3490.00%
Other shareholders
ARENA PHARMACEUTICALS INC shareholders Q3 2017
NameSharesValueWeighting ↓
Prosight Management, LP 164,300$9,633,0004.86%
Atika Capital Management LLC 230,000$13,485,0002.65%
DAFNA Capital Management LLC 93,942$5,508,0002.07%
PFM Health Sciences, LP 1,828,378$107,198,0002.04%
Perceptive Advisors 1,380,171$80,919,0001.86%
Eversept Partners, LP 73,501$4,309,3641.21%
Partner Investment Management, L.P. 18,159$1,065,0001.13%
Rhenman & Partners Asset Management AB 170,000$9,967,0001.10%
EMERALD ADVISERS, LLC 425,510$24,948,0001.00%
EMERALD MUTUAL FUND ADVISERS TRUST 388,418$22,773,0000.90%
View complete list of ARENA PHARMACEUTICALS INC shareholders